EGPO
NXTM

EnTrust Global Partners Offshore’s NxStage Medical Inc. NXTM Stock Holding History

EnTrust Global Partners Offshore’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-266,500
Closed -$6.46M – 90
2017
Q4 		$6.46M Buy
+266,500
New +$7.02M 2.13% 12

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EnTrust Global Partners Offshore's NXTM Position: Q1 2018 in Review

EnTrust Global Partners Offshore sold out of NxStage Medical Inc. (NXTM) in Q1 2018, closing a stake of 266,500 shares — an estimated $6.46M sold.

EnTrust Global Partners Offshore first reported a position in NXTM in Q4 2017 and held it in 1 quarter. The position peaked at $6.46M in Q4 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q1 2018.

  • EnTrust Global Partners Offshore reported no remaining NxStage Medical Inc. position as of Q1 2018 after selling out during the quarter.
  • EnTrust Global Partners Offshore sold 266,500 NxStage Medical Inc. shares in Q1 2018, an estimated $6.46M.
  • EnTrust Global Partners Offshore first reported a position in NxStage Medical Inc. in Q4 2017 and held it in 1 quarter.
  • EnTrust Global Partners Offshore's NxStage Medical Inc. position peaked at $6.46M in Q4 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2018.

Based on EnTrust Global Partners Offshore's 13F filing for Q1 2018, filed 15 May 2018.